The Pharmaceutical Sector is at Default Risk. A Proposal to Re-Establish the Economic Balance and Define a New Governance

Il settore farmaceutico rischia il default. Proposte per ristabilire l'equilibrio economico e per definire una nuova governance strutturale

Authors

  • Nello Martini Direttore Ricerca e Sviluppo Accademia Nazionale di Medicina, Roma - Italy

DOI:

https://doi.org/10.33393/grhta.2015.324

Keywords:

Drug expenditure, Formulary governance, Pharmaceutical sector

Abstract

The pharmaceutical governance in Italy is provided by a cap applied as a percentage of the National Health Fund to the territorial (11.35%) and hospital expenditure (3.5%). The amount of overspending is charged to the pharmaceutical companies with a payback procedure. For the years 2014-2016 the overspending is estimated at about 3.8 billion euros, which is likely to result in a system default. In this article a new pharmaceutical governance is proposed and discussed; its aim is to avoid financial imbalance and to identify appropriate measures to bridge the gap between the very high prices of new/innovative drugs and the system sustainability.

Downloads

Published

2015-03-17

How to Cite

1.
Martini N. The Pharmaceutical Sector is at Default Risk. A Proposal to Re-Establish the Economic Balance and Define a New Governance: Il settore farmaceutico rischia il default. Proposte per ristabilire l’equilibrio economico e per definire una nuova governance strutturale. Grhta [Internet]. 2015 Mar. 17 [cited 2022 Aug. 15];2(1):53-8. Available from: https://journals.aboutscience.eu/index.php/grhta/article/view/324

Issue

Section

Point of View

Most read articles by the same author(s)